ORGANOGENESIS HOLDINGS INC. Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions of $111.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-16.
Discontinued › Notes › Income Taxes
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions · last filed 2021-03-16
- ORGANOGENESIS HOLDINGS INC. unrecognized tax benefits, decrease resulting from current period tax positions for fiscal 2020 was $111.00K, a 16.54% decline from fiscal 2019.
- ORGANOGENESIS HOLDINGS INC. unrecognized tax benefits, decrease resulting from current period tax positions for fiscal 2019 was $133.00K, a 15.29% decline from fiscal 2018.
- ORGANOGENESIS HOLDINGS INC. unrecognized tax benefits, decrease resulting from current period tax positions for fiscal 2018 was $157.00K, a 0.00% change from fiscal 2017.
- ORGANOGENESIS HOLDINGS INC. unrecognized tax benefits, decrease resulting from current period tax positions for fiscal 2017 was $157.00K, a 32.03% decline from fiscal 2016.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions 12 month | Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions 12 month as first filed |
|---|---|---|
| 2020-12-31 | $111.00K 10-K · filed 2021-03-16 | |
| 2019-12-31 | $133.00K 10-K · filed 2021-03-16 | |
| 2018-12-31 | $157.00K 10-K · filed 2021-03-16 | |
| 2017-12-31 | $157.00K 10-K · filed 2020-03-09 | $231.00K 10-K · filed 2019-03-18 |
| 2016-12-31 | $231.00K 10-K · filed 2020-03-09 | $325.00K 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |